A Phase 2 interventional study of Tai Chi and Strength training in Parkinson's Disease, sponsored by Oregon Research Institute. Completed at 1 site in United States. Open to participants aged 40 Years to 85 Years. Per ClinicalTrials.gov, last updated 2011-10-12.
Sponsored by Oregon Research Institute · Phase 2, Interventional, and Treatment
Patients practicing Tai Chi will exhibit significant improvements in primary outcome measures of balance, and secondary outcomes of gait, physical performance, Unified Parkinson's Disease Rating Scale, Falls, muscle strength.
The study is designed to determine the effects of Tai Chi training on balance and other functional outcomes in persons with Parkinson's disease.
4,484 studies on the registry are indexed under Parkinson Disease; 1,081 are open to participants now.
This study's enrollment of 195 is above the median of 40 across 3,293 interventional studies indexed under Parkinson Disease.
Browse Parkinson Disease studies →Oregon Research Institute is the lead sponsor of 70 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients who have:
Exclusion Criteria:
Patients who:
Behavioral: Tai Chi
Behavioral: Strength training
Behavioral: Low-Impact Exercise Control
a set of pre-designed Tai Chi Movements
Lower-extremity strength training exercises
a set of chair-based low-impact exercises
Balance
Time frame: 3 time points
gait, physical performance, Unified Parkinson's Disease Rating Scale, falls, Muscle strength
Time frame: 3 time points
This study is completed, as verified in Oct 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oregon Research Institute